Ex-Aphria CEO Vic Neufeld Joins Psychedelics Industry

One of the early leading figures of the regulated Canadian cannabis industry is back as a member of a brand new psychedelics company.

Vic Neufeld, co-founder and the former CEO of Aphria (NASDAQ:APHA,TSX:APHA), has been announced as a director of Havn Life Sciences (CSE:HAVN), which went public this week.

The move marks Neufeld’s return to the spotlight after departing from Aphria in January 2019.


New FREE Report: Investing in Psychedelics

What’s ahead for this exciting new segment? Learn more with our exclusive psychedelics report today.

“It’s something that we really need to have a better understanding of — the standardization, the efficacy, the safety (of psychedelics) so researchers … can take it to the next level,” Neufeld said about the need to invest and develop work on novel drugs based on psychedelic substances.

According Havn Life co-CEO Susan Chapelle, the firm plans to develop product formulations for the microdosing of “novel psychoactive compounds” alongside extraction methodology in a mycology lab.

On Thursday (September 10), the company confirmed it has obtained a Section 56 exemption from Health Canada, meaning it is now allowed to “possess certain amounts of pure psilocybin for scientific purposes, specifically for the research and development of quality control methods.”

Psychedelics could attract big-name acquisitions

During his time in cannabis, Neufeld was witness to deals that allowed Fortune 500 companies to enter the space, along with a rush of rumors about potential acquisitions and investment deals.

Neufeld detailed how despite Aphria’s numerous conversations with pharmaceutical names, he understood no deal would take place given the finicky nature of patented intellectual property and products when it comes to the cannabis plant.

While very early on in its financial markets development, psychedelics is already attracting attention from the pharmaceutical space, according to several experts and observers of the industry.

Neufeld enters new work life with psychedelics play

Neufeld stepped down from Aphria, alongside fellow co-founder Cole Cacciavillani, following short seller claims lobbed against the company and its assets in the Latin America cannabis market.

At the time of his departure, Neufeld cited the taxing nature of the cannabis business on his health as a principal reason for calling it quits. “The last five years have been incredible. But to be brutally honest, this journey has taken a toll on my health, family and other priorities,” Neufeld said during a conference call, according to a report from the Financial Post.

In response to how he plans to better balance work and life this time around, Neufeld said he will not be involved with the day-to-day operations of Havn Life. “In simple words, no more heavy lifting for me,” he said. “It’s very demanding, it’s all consuming. You put aside all of your other family type of priorities because business took over and it was all consuming.”

The company isn’t counting on Neufeld as its only expert voice coming from the cannabis public markets. Rick Brar, former CEO of Zenabis Global (TSX:ZENA), is a director at Havn Life as well.

Check out the video above to hear the full talk with Neufeld, and click here if you’d like to get familiarized with listed psychedelics companies.

Don’t forget to follow us @INN_LifeScience for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.


New FREE Report: Investing in Psychedelics

What’s ahead for this exciting new segment? Learn more with our exclusive psychedelics report today.

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less